Pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 173A of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed Monitoring Agency Report towards utilization of proceeds of Qualified Institutions Placement ( QIP ) for the quarter ended September 30, 2025, issued by CRISIL Ratings Limited, duly reviewed and taken on record by the Board of Directors & Audit Committee of the Company.
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Wockhardt Limited submitted the Monitoring Agency Report from CRISIL Ratings for the quarter ended September 30, 2025, confirming no deviation from the stated objects of its Qualified Institutional Placement (QIP) of equity shares held in November 2024. The QIP raised gross proceeds of Rs 1,000 crore (net Rs 977.79 crore), allocated across three purposes: Rs 500 crore for debt repayment, Rs 250 crore for capex and R&D, and Rs 227.79 crore for general corporate purposes. During Q2 FY26, the company utilized Rs 157.61 crore (cumulative utilization of Rs 740.68 crore), with Rs 237.11 crore remaining unutilized and parked in mutual funds and current accounts. The monitoring agency noted that during the quarter, mutual fund holdings were redeemed and proceeds were credited directly to operational cash credit accounts, with Rs 157.61 crore used from these accounts for the stated objects.
This is a routine regulatory compliance filing confirming disciplined use of QIP funds without deviation. Shareholders can be assured that the Rs 1,000 crore raised in November 2024 is being deployed as planned — largely for debt reduction, with meaningful progress on R&D and capex spending. The relatively slow utilization of the R&D/capex allocation (only Rs 52.50 crore used out of Rs 250 crore) and the shift of funds through operational accounts are minor items to watch but not red flags.